The Veterinary Medicinal Products Regulation (Regulation (EU) 2019/6) contains new legal provisions on veterinary pharmacovigilance. These aim to focus on continuous signal management based on adverse event data in the ‘Union Pharmacovigilance Database’ and cover pharmacovigilance inspections and the maintenance of pharmacovigilance master files. To assist marketing authorization holders in fulfilling their pharmacovigilance obligations, the […]
Pharmacovigilance
Consulting firms AZIERTA and PVPHARM sign strategic alliance in the are of Pharmacovigilance
The Partnership will work together to design and market advanced pharmacovigilance services in Spain and abroad. The Partnership will be the sector leader in Spain for providing comprehensive pharmacovigilance services and a European benchmark. Madrid, March 2020. AZIERTA, a global science and health consultancy firm specialised in accompanying the health industry in its scientific development, […]
Updated guidance on pharmacovigilance procedures
The Medicines and Healthcare products Regulatory Agency (MHRA) published a pharmacovigilance update for 2021, when the transition period for Brexit ends. If there are no changes in the coming months, from January 2021 all pharmacovigilance activities for UK authorised products will have to be managed according to the indications on this link or by clicking on the image below.
Recent Comments